Stoke Therapeutics, Inc. · NASDAQ:STOK
Toronto Dominion Bank reported a 5.80% stake in Stoke Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Toronto Dominion Bank reported a 5.80% stake in Stoke Therapeutics, Inc., 3,173,258 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 3,173,258
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Toronto-Dominion Bank | 5.80% | 3,173,258 |
Source
Related
- Stoke Therapeutics, Inc.
- Toronto Dominion Bank
- Stoke Therapeutics, Inc. shareholders
- Schedule 13G/A · Toronto Dominion Bank · Aug 12, 2026
- Schedule 13G/A · Toronto Dominion Bank · May 15, 2026
- Form 4 · Allan Jonathan · Oct 2, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026